ARTICLE ABSTRACT
The movement toward sharing data from clinical trials has divided the scientific community, and the battle lines were evident at a recent summit sponsored by the Journal. On one side stand many clinical trialists, whose lifeblood — randomized, controlled trials (RCTs) — may be threatened by data sharing. On the other side stand data scientists — many of them hailing from the genetics community, whose sharing of data markedly accelerated progress in that field.
Link to access full article:http://www.nejm.org/doi/full/10.1056/NEJMp1704482
Please Sign in (or Register) to view further.